Norton Cancer Institute, St. Matthews Campus

Louisville, Kentucky 40207

4 studies enrolling now · 23 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemias, Adenoid Cystic Carcinoma, Advanced Breast Cancer, Breast Cancer, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, Carcinoma, Transitional Cell, Cervical Cancer, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

Studies at this site

• A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies — Recruiting now
• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — Recruiting now
• Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer — Recruiting now
• A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies — Recruiting now
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias — Running, not enrolling
• PF-07104091 as a Single Agent and in Combination Therapy — Running, not enrolling
• FT819 in Subjects With B-cell Malignancies — Running, not enrolling
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS — Completed
• Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma — Running, not enrolling
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma — Stopped early
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer — Completed
• Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia — Stopped early
• Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma — Stopped early
• A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
• A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies — Completed
• Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma — Completed
• An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia — Stopped early
• NLA101 in Adults Receiving High Dose Chemotherapy for AML — Stopped early